| Product Code: ETC10200837 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Active and Intelligent Packaging in Pharmaceutical Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 China Active and Intelligent Packaging in Pharmaceutical Market - Industry Life Cycle |
3.4 China Active and Intelligent Packaging in Pharmaceutical Market - Porter's Five Forces |
3.5 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Active and Intelligent Packaging in Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and product integrity in the pharmaceutical industry |
4.2.2 Growing demand for extended shelf-life and improved product quality |
4.2.3 Regulatory requirements for track and trace capabilities in the supply chain |
4.3 Market Restraints |
4.3.1 High initial investment and implementation costs of active and intelligent packaging technologies |
4.3.2 Lack of awareness and understanding among pharmaceutical manufacturers about the benefits of these technologies |
4.3.3 Concerns regarding the compatibility of active packaging with different pharmaceutical products |
5 China Active and Intelligent Packaging in Pharmaceutical Market Trends |
6 China Active and Intelligent Packaging in Pharmaceutical Market, By Types |
6.1 China Active and Intelligent Packaging in Pharmaceutical Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Near Field Communication (NFC), 2021 - 2031F |
6.1.4 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Radio Frequency Identification (RFID), 2021 - 2031F |
6.1.5 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Time-Temperature Indicators (TTIs), 2021 - 2031F |
6.1.6 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Gas Scavengers, 2021 - 2031F |
6.1.7 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Moisture Control Packaging, 2021 - 2031F |
6.1.8 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Thermochromic Ink Packaging, 2021 - 2029F |
6.1.9 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2029F |
6.1.10 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2029F |
6.2 China Active and Intelligent Packaging in Pharmaceutical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Product Authentication, 2021 - 2031F |
6.2.3 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Anti-Counterfeiting Measures, 2021 - 2031F |
6.2.4 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Patient Compliance Monitoring, 2021 - 2031F |
6.2.5 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Supply Chain Management, 2021 - 2031F |
6.2.6 China Active and Intelligent Packaging in Pharmaceutical Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Active and Intelligent Packaging in Pharmaceutical Market Import-Export Trade Statistics |
7.1 China Active and Intelligent Packaging in Pharmaceutical Market Export to Major Countries |
7.2 China Active and Intelligent Packaging in Pharmaceutical Market Imports from Major Countries |
8 China Active and Intelligent Packaging in Pharmaceutical Market Key Performance Indicators |
8.1 Percentage reduction in product recalls due to improved packaging |
8.2 Number of regulatory compliance standards met by active and intelligent packaging solutions |
8.3 Increase in adoption rate of active and intelligent packaging technologies by pharmaceutical companies |
8.4 Percentage increase in product shelf-life attributed to active packaging |
8.5 Number of successful track and trace operations implemented using intelligent packaging technology |
9 China Active and Intelligent Packaging in Pharmaceutical Market - Opportunity Assessment |
9.1 China Active and Intelligent Packaging in Pharmaceutical Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 China Active and Intelligent Packaging in Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Active and Intelligent Packaging in Pharmaceutical Market - Competitive Landscape |
10.1 China Active and Intelligent Packaging in Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 China Active and Intelligent Packaging in Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here